Intended use: Deficient plasmas to be used in combination with the selected PT reagent for the determination of specific Factor activity in citrated plasma on IL Coagulation and ELECTRA systems.
Principle: Each deficient plasma is specifically deficient in the corresponding Factor at a minimum level: < 1%. All remaining Factors are at the optimal level to assure proper performance in the plasma being assayed. Deficient plasmas are obtained using immunodepletion technology. All deficient plasmas are tested and found nonreactive for hepatitis B, C and HIV.
Vials and volumes:
- 5 x 1 mL Factor Deficient Plasma (lyo)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
